Transplacental passage of the non-ionic contrast agent iopamidol in twins

Fitzpatrick, Joseph P.; Speakman, Julie; Kapfer, Stephanie A.

doi:10.1007/s00247-010-1888-z

Cited by 4 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Iopamidol (Isovue) is a nonionic, low osmolarity, monomeric iodine agent which passes the placenta barrier. It has been demonstrated to be safe for fetal thyroid function, reproductive outcomes, and teratogenic effects in animals [ 15 , 16 ]. Iopromide (Ultravist) is the most used iodine contrast agent in CT: it is a nonionic, low osmolarity, and hydrosoluble agent with a transplacental passage.…”

Section: Classification Of Contrast Agentsmentioning

confidence: 99%

Contrast Agents during Pregnancy: Pros and Cons When Really Needed

Perelli

Turrini

Giorgi

et al. 2022

IJERPH

View full text Add to dashboard Cite

Many clinical conditions require radiological diagnostic exams based on the emission of different kinds of energy and the use of contrast agents, such as computerized tomography (CT), positron emission tomography (PET), magnetic resonance (MR), ultrasound (US), and X-ray imaging. Pregnant patients who should be submitted for diagnostic examinations with contrast agents represent a group of patients with whom it is necessary to consider both maternal and fetal effects. Radiological examinations use different types of contrast media, the most used and studied are represented by iodinate contrast agents, gadolinium, fluorodeoxyglucose, gastrographin, bariumsulfate, and nanobubbles used in contrast-enhanced ultrasound (CEUS). The present paper reports the available data about each contrast agent and its effect related to the mother and fetus. This review aims to clarify the clinical practices to follow in cases where a radiodiagnostic examination with a contrast medium is indicated to be performed on a pregnant patient.

show abstract

Section: Classification Of Contrast Agentsmentioning

confidence: 99%